Indiana University Health, as well as a partnership of Franciscan Alliance and American Health Network, have formed accountable care organizations that won the blessing of the federal Medicare Shared Savings program.
Eli Lilly and Co. said Friday that it has received an extra six months of marketing exclusivity on the antidepressant Cymbalta, its biggest selling drug. The extension could mean more than a billion dollars in sales for the Indianapolis drug maker.
When Helene Cross arrived to lead Fairbanks Addiction Treatment Center in 2001, the alcohol and drug rehabilitation hospital was as sick financially as its patients were physically.
The great results Regenstrief Institute has produced over the years in studies at Indianapolis’ Wishard Memorial Hospital have not held up when conducted in a wider variety of settings.
Bristol-Myers Squibb Co. has agreed to pay $5.3 billion to acquire former Eli Lilly and Co. partner Amylin Pharmaceuticals Inc., a maker of diabetes therapies. The deal is valued at about $7 billion, which includes Amylin’s debt and a payment to Eli Lilly and Co. of about $1.7 billion.
The U.S. Supreme Court’s ruling to uphold the Patient Protection & Affordable Care Act cleared a big cloud of uncertainty for employers, but with just 18 months before the most significant provisions of the law kick in, many questions remain. Three benefits consultants from Indianapolis-based Gregory & Appel Insurance—Bob Miller, Mike Miles and Karl Ahlrichs—sat down to discuss what the future looks like for employer health benefits.
The Supreme Court's decision Thursday to uphold President Barack Obama's historic overhaul is expected to boost many players in the health care industry, but not every corner of the sector will benefit.
While upholding President Obama’s health care law, the U.S. Supreme Court may have created a way out for states that do not want to expand their Medicaid programs. Whether Indiana decides to opt out remains to be seen.
A decision by Indiana to leave its Medicaid program unchanged could leave as many as 290,000 Hoosier adults, who would have been newly eligible for Medicaid coverage, with no good options.
Stocks of hospital companies rose sharply and insurance companies fell Thursday after the Supreme Court upheld a requirement that almost all Americans carry health insurance. WellPoint shares were down more than 5 percent.
The U.S. Supreme Court has upheld the core of President Barack Obama’s health-care overhaul, preserving most of a law that would expand insurance to millions of people and transform an industry that makes up 18 percent of the nation’s economy.
The New Jersey-based pharmaceutical research company is seeking state and local incentives as part of the expansion, which would include a new laboratory, set to be finished in 2016. Covance already employs 565 workers at the site.
The university says the gift from an alumnus will fund three new endowed professorships in adult and all forms of non-embryonic stem cell research, in hopes of accelerating discovery of new treatments for heart disease, diabetes and some cancers.
To comply with the statewide smoking ban that begins July 1, there's more for businesses to do than stop patrons and employees from smoking indoors. The same law compels businesses to post an array of signs that announce the ban.
If approved for acute coronary syndrome, Xarelto would compete with Effient from Indianapolis-based Eli Lilly and Co and Brilinta from London-based AstraZeneca Plc.
The local pharmaceutical giant plans to complete the program started in 2000 by repurchasing $420 million in shares by the end of the year. And on Tuesday, it declared a regular dividend of 49 cents.
The U.S. Supreme Court did not hand down a ruling in the health care reform case Monday morning. The nine justices meet again Thursday, but most observers expect the decision to come June 25 or June 28.
Sam Odle, one of Indianapolis’ most prominent black business leaders, will be replaced on an interim basis by Jim Terwilliger while the hospital system conducts a national search for his successor.
Crohn’s and Colitis Foundation's mission is to cure Crohn's disease and ulcerative colitis, and improve the quality of life of children and adults affected by these diseases.
Fishers-based Cancer-Free Lungs decided last year it was ready to shut down.
